货号：UP477980440
| 产品信息 | |
| 产品名称： | (4R,4'R)-2,2'-(Propane-2,2-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole) |
| 中文名称： | (4R,4'R)-2,2'-(丙烷-2,2-二基)双(4-(叔丁基)-4,5-二氢噁唑)(请以英文为准,中文仅做参考) |
| CAS号： | 131833-97-1 |
| 分子式： | C17H30N2O2 |
| 分子量： | 294.43 |
| MDL NO： | MFCD07368371 |
| 标准纯度： | 97% (UP477980440) |
| 沸点： | 350.424°C at 760 mmHg |
| 储存： | Sealed in dry,Room Temperature (UP477980440) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
PAP-1
UP348854274870653-45-5
4,4'-Dimethyl-2,2'-bipyridine
UP5473286281134-35-6
PROTAC TBK1 C3i
UP4450681032052306-13-3
2-Phenoxyethanol
UP308003767122-99-6
Triethyl phosphate
UP88432719678-40-0
TAK-438
UP9001998691260141-27-2
4-Pyridinemethanol
UP415124791586-95-8
TDZD-8
UP883087541327036-89-5
2-Hydroxy-4-nitrobenzaldehyde
UP5477592202460-58-4
Empagliflozin
UP372853798864070-44-0
6-Methyleneandrost-4-ene-3,17-dione
UP87630815519457-55-7
4-Bromo-2-fluoroaniline
UP443509312367-24-8
2-Vinylthiophene
UP2783408031918-82-7
PYZD-4409
UP982889737423148-78-1
NSC 632839 Hydrochloride
UP957281530157654-67-6
Diphenylsilanediol
UP920377837947-42-2
Aminomethyl Polystyrene Resin 100-200 mesh, 1% DVB
UP470328177489551-24-6
Dimethyl adipate
UP382433603627-93-0
4-Bromo-2-hydroxy-6-methylbenzaldehyde
UP5126542711427438-58-1
1-Fluoro-2-methyl-4-nitrobenzene
UP164943283455-88-9
Ethyl 2-(diethoxyphosphoryl)propanoate
UP4933523853699-66-9
Tofogliflozin
UP924104312903565-83-3
5-Chlorothiophene-2-carbonyl chloride
UP56012497542518-98-9
Minoxidil
UP62209459338304-91-5
2,6-Bis((R)-4-phenyl-4,5-dihydrooxazol-2-yl)pyridine
UP112848717128249-70-7
Bioymifi
UP1875223931420071-30-2
4-Chloro-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazoline
UP947687320264208-72-2
Vandetanib
UP138794460443913-73-3
BKM-120
UP511161334944396-07-0
Nutlin 3
UP489317710548472-68-0
NVP-ADW742
UP173568943475488-23-4
DMXAA
UP191798647117570-53-3
Nutlin 3a
UP310160663675576-98-4
(S)-1-(Benzylideneamino)-3-chloropropan-2-ol
UP942283373224323-52-8
2-deoxy-D-Glucose
UP225160710154-17-6
Diethyl ((5-bromopyridin-2-yl)methyl)phosphonate
UP872009198380893-73-2
DGAT1 Inhibitor 2
UP831508051942999-61-3
Ro 31-8220
UP197384040125314-64-9
DUBs-IN-2
UP952505638924296-19-5
3-Amino-1,2-propanediol
UP190824080616-30-8
2-(2-Bromoethyl)-1,3-dioxolane
UP23610874918742-02-4
6-Chloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purine
UP6293429567306-68-5
N-((1R,2R)-2-Amino-1,2-diphenylethyl)-4-methylbenzenesulfonamide
UP584500179144222-34-4
2,2'-(Methylazanediyl)diacetic acid
UP6571757404408-64-4
4-((5-(((Cyclopentyloxy)carbonyl)amino)-1-methyl-1H-indol-3-yl)methyl)-3-methoxybenzoic acid
UP539494014107754-20-1
ML402
UP617500809298684-44-3
USP7-IN-1
UP8906445501381291-36-6
Methyl 4-bromo-5-(difluoromethyl)thiophene-2-carboxylate
UP3438402321207557-47-8
N-(Benzyloxycarbonyloxy)succinimide
UP51037009613139-17-8
PX-12
UP331485835141400-58-0
1-Bromo-2,3,5,6-tetrafluoro-4-(trifluoromethyl)benzene
UP52070269517823-46-0
Huperzine A
UP759289196102518-79-6
Boc-Arg(Tos)-OH
UP99376209913836-37-8
2-Hydroxyisoindoline-1,3-dione
UP261296730524-38-9
Nefopam hydrochloride
UP24821656323327-57-3
5-Chloro-1H-pyrrolo[2,3-b]pyridine
UP967295356866546-07-8
Canagliflozin
UP318278463842133-18-0
Methyl 3-(benzyloxy)-5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate
UP4659212181229006-21-6
MK-571 Sodium
UP219177215115103-85-0
PF-04457845
UP1771468001020315-31-4
Methyl 1,2,5,6-tetrahydropyridine-3-carboxylate
UP447698338495-19-2
Brigatinib
UP6952822601197953-54-0
JNJ-42165279
UP6316733651346528-50-4
USP7-USP47 inhibitor
UP5422576731247825-37-1
1alpha-Hydroxy VD4
UP537410023143032-85-3
DUBs-IN-1
UP791858969924296-18-4
GW2580
UP992960108870483-87-7
MK2-IN-1
UP5110525981314118-92-7
AZM475271
UP631612555476159-98-5
JZL 195
UP6780968701210004-12-8
4-Iodoanisole
UP878509570696-62-8
Thalidomide
UP57239321250-35-1
Entrectinib
UP8552007211108743-60-7
alpha-Viniferin
UP94366996062218-13-7
(4R,4'R)-2,2'-(Propane-2,2-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole)
UP477980440131833-97-1